The acute lymphoblastic leukemia therapeutics market reached USD 3.38 Billion in 2024, driven by rising leukemia cases and innovations in immunotherapy and targeted treatments. The market is expected to grow at a CAGR of 6.70% to reach USD 6.46 Billion by 2034. https://www.expertmarketresearch.com/reports/acute-lymphoblastic-leukemia-therapeutics-market